Morgan Stanley Upgrades Lineage to Overweight, Maintains Price Target to $47
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsUpgradesPrice Target
Morgan Stanley analyst Ronald Kamdem upgrades Lineage (NASDAQ:LINE) from Equal-Weight to Overweight and maintains the price target from $47 to $47.
Morgan Stanley analyst Ronald Kamdem upgrades Lineage (NASDAQ:LINE) from Equal-Weight to Overweight and maintains the price target from $47 to $47.